Felix Silke, Sandjo Louis P, Opatz Till, Erkel Gerhard
Institute of Biotechnology and Drug Research (IBWF), Erwin-Schrödinger-Strasse 56, D-67663 Kaiserslautern, Germany.
Institute of Organic Chemistry, University of Mainz, Duesbergweg 10-14, D-55128 Mainz, Germany.
Bioorg Med Chem. 2014 Jun 1;22(11):2912-8. doi: 10.1016/j.bmc.2014.04.015. Epub 2014 Apr 18.
IFN-γ inducible protein 10 (IP-10, CXCL10) is a 10 kDa chemokine, which is secreted from various cell types after exposure to pro-inflammatory stimuli. This chemokine is a ligand for the CXCR3 receptor and regulates immune responses by activating and recruiting leukocytes such as T cells, eosinophils, monocytes, and NK cells to sites of inflammation. Altered expression of CXCL10 has been associated with chronic inflammatory and infectious diseases and therefore CXCL10 represents a promising target for the development of new anti-inflammatory drugs. In a search for inhibitors of CXCL10 promoter activity, three structurally related drimane sesquiterpene lactones (compounds 1-3) were isolated from fermentations of an Aspergillus species. Compounds 1 and 2 inhibited the IFN-γ/TNF-α/IL-1β induced CXCL10 promoter activity in transiently transfected human DLD-1 colon carcinoma cells in a dose-dependent manner with IC50 values of 12.4 μM for 1 and 55 μM for 2, whereas 3 was devoid of any biological activity. Moreover, compounds 1 and 2 reduced CXCL10 mRNA levels and synthesis in IFN-γ/TNF-α/IL-1β stimulated DLD-1 cells.
γ干扰素诱导蛋白10(IP - 10,CXCL10)是一种10 kDa的趋化因子,在暴露于促炎刺激后由多种细胞类型分泌。这种趋化因子是CXCR3受体的配体,通过激活和募集白细胞(如T细胞、嗜酸性粒细胞、单核细胞和自然杀伤细胞)到炎症部位来调节免疫反应。CXCL10表达的改变与慢性炎症和感染性疾病有关,因此CXCL10是开发新型抗炎药物的一个有前景的靶点。在寻找CXCL10启动子活性抑制剂的过程中,从一种曲霉菌的发酵产物中分离出了三种结构相关的杜松烷倍半萜内酯(化合物1 - 3)。化合物1和2以剂量依赖性方式抑制了在瞬时转染的人DLD - 1结肠癌细胞中由γ干扰素/肿瘤坏死因子 - α/白细胞介素 - 1β诱导的CXCL10启动子活性,化合物1的IC50值为12.4 μM,化合物2的IC50值为55 μM,而化合物3没有任何生物活性。此外,化合物1和2降低了在γ干扰素/肿瘤坏死因子 - α/白细胞介素 - 1β刺激的DLD - 1细胞中CXCL10的mRNA水平和合成。